ABBV - AbbVie Inc.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.
As of May 15, 2026: spot at $210.80, ATM IV 25.8%, max pain $210.00, net GEX $19.7M.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Market Cap
- $368.38B
- P/E Ratio
- 101.64
- Beta
- 0.30
- 52-Week Range
- 176.57-244.81
- Dividend Yield
- $6.74
- CEO
- Robert A. Michael
- Employees
- 55,000
- IPO Date
- Jan 2, 2013
- Exchange
- NYSE
What ABBV Looks Like to Options Traders Today
IV rank of 43.9% sits near the 1-year median, where strategy choice depends on directional conviction and the event calendar rather than vol regime alone; positive net gamma exposure ($19.7M) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (0.025) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The ABBV overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked ABBV overview questions
- What is ABBV?
- ABBV is the ticker symbol for AbbVie Inc., a listed security. AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. Listed on NYSE. ABBV is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the ABBV options snapshot look like today?
- As of May 15, 2026, the ABBV options snapshot shows spot at $210.80, ATM IV 25.8%, IV rank 43.9%, max pain $210.00, net GEX $19.7M, expected move 7.41%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are ABBV's key statistics?
- AbbVie Inc. (ABBV) carries a market capitalization of $368.38B, trailing P/E ratio of 101.64, beta of 0.30 relative to the broader market, 52-week range of 176.57-244.81. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does ABBV belong to?
- AbbVie Inc. operates in the Healthcare sector, in the Drug Manufacturers - General industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare ABBV's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the ABBV data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).